Get startedLog in
    Picture of INDOCO REMEDIES logo

    INDOCO — INDOCO REMEDIES Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for INDOCO REMEDIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue11,06612,41515,40816,68618,173
    Cost of Revenue
    Gross Profit7,2658,34510,18410,78711,792
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses10,53910,90112,91814,51716,524
    Operating Profit5261,5142,4892,1691,649
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes2861,3202,3661,9281,358
    Provision for Income Taxes
    Net Income After Taxes2419301,5481,423970
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income2419301,5481,423985
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income2419301,5481,423985
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS2.910.11715.59.81
    Dividends per Share
    Special Dividends per Share